Unknown

Dataset Information

0

Diagnostic value and characteristic analysis of serum nucleocapsid antigen in COVID-19 patients.


ABSTRACT:

Background

To date, several types of laboratory tests for coronavirus disease 2019 (COVID-19) diagnosis have been developed. However, the clinical importance of serum severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid antigen (N-Ag) remains to be fully elucidated. In this study, we sought to investigate the value of serum SARS-CoV-2 N-Ag for COVID-19 diagnosis and to analyze N-Ag characteristics in COVID-19 individuals.

Methods

Serum samples collected from 215 COVID-19 patients and 65 non-COVID-19 individuals were used to quantitatively detect N-Ag via chemiluminescent immunoassay according to the manufacturer's instructions.

Results

The sensitivity and specificity of the N-Ag assay were 64.75% (95% confidence interval (95% CI) [55.94-72.66%]) and 100% (95% CI [93.05-100.00%]), respectively, according to the cut-off value recommended by the manufacturer. The receiver operating characteristic (ROC) curve showed a sensitivity of 100.00% (95% CI [94.42-100.00%]) and a specificity of 71.31% (95% CI [62.73-78.59%]). The positive rates and levels of serum SARS-CoV-2 N-Ag were not related to sex, comorbidity status or disease severity of COVID-19 (all P < 0.001). Compared with RT‒PCR, there was a lower positive rate of serum N-Ag for acute COVID-19 patients (P < 0.001). The positive rate and levels of serum SARS-CoV-2 N-Ag in acute patients were significantly higher than those in convalescent patients (all P < 0.001). In addition, the positive rate of serum SARS-CoV-2 N-Ag in acute COVID-19 patients was higher than that of serum antibodies (IgM, IgG, IgA and neutralizing antibodies (Nab)) against SARS-CoV-2 (all P < 0.001). However, the positive rate of serum SARS-CoV-2 N-Ag in convalescent COVID-19 patients was significantly lower than that of antibodies (all P < 0.001).

Conclusion

Serum N-Ag can be used as a biomarker for early COVID-19 diagnosis based on appropriate cut-off values. In addition, our study also demonstrated the relationship between serum N-Ag and clinical characteristics.

SUBMITTER: Zhang X 

PROVIDER: S-EPMC10257392 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature

altmetric image

Publications

Diagnostic value and characteristic analysis of serum nucleocapsid antigen in COVID-19 patients.

Zhang Xihong X   Qian Chungen C   Yang Li L   Gao Huixia H   Jiang Ping P   Dai Muwei M   Wang Yuling Y   Kang Haiyan H   Xu Yi Y   Hu Qian Q   Feng Fumin F   Cheng Bangning B   Dai Erhei E  

PeerJ 20230607


<h4>Background</h4>To date, several types of laboratory tests for coronavirus disease 2019 (COVID-19) diagnosis have been developed. However, the clinical importance of serum severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid antigen (N-Ag) remains to be fully elucidated. In this study, we sought to investigate the value of serum SARS-CoV-2 N-Ag for COVID-19 diagnosis and to analyze N-Ag characteristics in COVID-19 individuals.<h4>Methods</h4>Serum samples collected from 2  ...[more]

Similar Datasets

| S-EPMC7939929 | biostudies-literature
| S-EPMC8762868 | biostudies-literature
| S-EPMC8546430 | biostudies-literature
2021-11-24 | GSE189506 | GEO
| S-EPMC8019489 | biostudies-literature
| S-EPMC9420199 | biostudies-literature
| S-EPMC8079120 | biostudies-literature
2021-05-10 | GSE169346 | GEO
| S-EPMC5687748 | biostudies-literature